Tech Company Financing Transactions
Neurocrine Biosciences Funding Round
Neurocrine Biosciences closed a $10 million funding round on 12/17/2009. Investors included Venrock.
Transaction Overview
Company Name
Announced On
12/17/2009
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
12780 El Camino Real
San Diego, CA 92130
USA
San Diego, CA 92130
USA
Phone
Website
Email Address
Overview
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) of San Diego is a product based biopharmaceutical company focusing on the development and commercialization of innovative pharmaceutical products to treat unmet medical needs.
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 12/17/2009: Inertia Beverage Group venture capital transaction
Next: 12/17/2009: RepairPal venture capital transaction
Share this article
News on VC Transactions
We do our best to report on every notable VC transaction. VC transactions reported here are derived from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs